ALHEX Fundamental Analysis - HEXAOM

Fundamental Rating

We assign a fundamental rating of 4 out of 10 to ALHEX. ALHEX was compared to 34 industry peers in the Household Durables industry. Both the profitability and the financial health of ALHEX get a neutral evaluation. Nothing too spectacular is happening here. ALHEX has a valuation in line with the averages, but on the other hand it scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year ALHEX was profitable.
ALHEX had a negative operating cash flow in the past year.
ALHEX had positive earnings in 4 of the past 5 years.
ALHEX had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

The Return On Assets of ALHEX (1.46%) is comparable to the rest of the industry.
ALHEX's Return On Equity of 3.94% is in line compared to the rest of the industry. ALHEX outperforms 50.00% of its industry peers.
With a Return On Invested Capital value of 3.70%, ALHEX perfoms like the industry average, outperforming 47.06% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for ALHEX is in line with the industry average of 9.16%.
The last Return On Invested Capital (3.70%) for ALHEX is well below the 3 year average (8.77%), which needs to be investigated, but indicates that ALHEX had better years and this may not be a problem.

		Industry Rank	Sector Rank
ROA	1.46%
ROE	3.94%
ROIC	3.7%

ROA(3y)1.03%

ROA(5y)1.76%

ROE(3y)1.4%

ROE(5y)4.65%

ROIC(3y)8.77%

ROIC(5y)8.58%

1.3 Margins

Looking at the Profit Margin, with a value of 1.46%, ALHEX is in line with its industry, outperforming 47.06% of the companies in the same industry.
In the last couple of years the Profit Margin of ALHEX has declined.
ALHEX has a Operating Margin of 2.30%. This is comparable to the rest of the industry: ALHEX outperforms 41.18% of its industry peers.
In the last couple of years the Operating Margin of ALHEX has declined.
Looking at the Gross Margin, with a value of 21.14%, ALHEX is doing worse than 79.41% of the companies in the same industry.
In the last couple of years the Gross Margin of ALHEX has remained more or less at the same level.

		Industry Rank	Sector Rank
OM	2.3%
PM (TTM)	1.46%
GM	21.14%

OM growth 3Y-6%

OM growth 5YN/A

PM growth 3Y-3.63%

PM growth 5YN/A

GM growth 3Y-1.02%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ALHEX is creating some value.
ALHEX has about the same amout of shares outstanding than it did 1 year ago.
The debt/assets ratio for ALHEX has been reduced compared to a year ago.

2.2 Solvency

ALHEX has an Altman-Z score of 2.13. This is not the best score and indicates that ALHEX is in the grey zone with still only limited risk for bankruptcy at the moment.
ALHEX has a Altman-Z score of 2.13. This is comparable to the rest of the industry: ALHEX outperforms 58.82% of its industry peers.
A Debt/Equity ratio of 0.40 indicates that ALHEX is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.40, ALHEX is doing good in the industry, outperforming 61.76% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.4
Debt/FCF	N/A
Altman-Z	2.13

ROIC/WACC0.53

WACC7.02%

2.3 Liquidity

A Current Ratio of 1.31 indicates that ALHEX should not have too much problems paying its short term obligations.
ALHEX's Current ratio of 1.31 is in line compared to the rest of the industry. ALHEX outperforms 44.12% of its industry peers.
A Quick Ratio of 0.99 indicates that ALHEX may have some problems paying its short term obligations.
With a decent Quick ratio value of 0.99, ALHEX is doing good in the industry, outperforming 64.71% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	1.31
Quick Ratio	0.99

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

ALHEX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -68.84%.
The earnings per share for ALHEX have been decreasing by -13.22% on average. This is quite bad
Looking at the last year, ALHEX shows a very negative growth in Revenue. The Revenue has decreased by -30.53% in the last year.
The Revenue has been decreasing by -9.93% on average over the past years.

EPS 1Y (TTM)-68.84%

EPS 3Y-13.22%

EPS 5YN/A

EPS Q2Q%-48.59%

Revenue 1Y (TTM)-30.53%

Revenue growth 3Y-9.93%

Revenue growth 5YN/A

Sales Q2Q%-26.54%

3.2 Future

ALHEX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 38.63% yearly.
Based on estimates for the next years, ALHEX will show a small growth in Revenue. The Revenue will grow by 3.02% on average per year.

EPS Next Y-12.2%

EPS Next 2Y38.63%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year-11.32%

Revenue Next 2Y2.8%

Revenue Next 3YN/A

Revenue Next 5Y3.02%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 26.26, which means the current valuation is very expensive for ALHEX.
Compared to the rest of the industry, the Price/Earnings ratio of ALHEX is on the same level as its industry peers.
ALHEX's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.33.
With a Price/Forward Earnings ratio of 8.48, the valuation of ALHEX can be described as very reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALHEX indicates a somewhat cheap valuation: ALHEX is cheaper than 67.65% of the companies listed in the same industry.
ALHEX is valuated cheaply when we compare the Price/Forward Earnings ratio to 24.12, which is the current average of the S&P500 Index.

		Industry Rank	Sector Rank
PE	26.26
Fwd PE	8.48

4.2 Price Multiples

ALHEX's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ALHEX is cheaper than 61.76% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	6.27

4.3 Compensation for Growth

ALHEX's earnings are expected to grow with 38.63% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y38.63%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.48%, ALHEX has a reasonable but not impressive dividend return.
ALHEX's Dividend Yield is comparable with the industry average which is at 2.66.
Compared to the average S&P500 Dividend Yield of 1.91, ALHEX is paying slightly less dividend.

		Industry Rank	Sector Rank
Dividend Yield	1.48%

5.2 History

Dividend Growth(5Y)N/A

Div Incr Years0

Div Non Decr Years0

5.3 Sustainability

DP0%

EPS Next 2Y38.63%

EPS Next 3YN/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

HEXAOM

EPA:ALHEX (1/14/2026, 7:00:00 PM)

34.4

+1.5 (+4.56%)

Chartmill FA Rating

GICS SectorConsumer Discretionary

GICS IndustryGroupConsumer Durables & Apparel

GICS IndustryHousehold Durables

Earnings (Last)11-07 2025-11-07

Earnings (Next)02-10 2026-02-10

Inst Owners15.33%

Inst Owner ChangeN/A

Ins Owners2.84%

Ins Owner ChangeN/A

Market Cap238.74M

Revenue(TTM)617.81M

Net Income(TTM)9.04M

Analysts86.67

Price Target46.41 (34.91%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	1.48%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)12.35%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)-33.58%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	26.26
Fwd PE	8.48
P/S	0.39
P/FCF	N/A
P/OCF	N/A
P/B	1.04
P/tB	2.36
EV/EBITDA	6.27

EPS(TTM)1.31

EY3.81%

EPS(NY)4.06

Fwd EY11.8%

FCF(TTM)-1.52

FCFYN/A

OCF(TTM)-0.85

OCFYN/A

SpS89.02

BVpS33.03

TBVpS14.6

PEG (NY)N/A

PEG (5Y)N/A

Graham Number31.2

Profitability

		Industry Rank	Sector Rank
ROA	1.46%
ROE	3.94%
ROCE	4.7%
ROIC	3.7%
ROICexc	6.23%
ROICexgc	17.99%
OM	2.3%
PM (TTM)	1.46%
GM	21.14%
FCFM	N/A

ROA(3y)1.03%

ROA(5y)1.76%

ROE(3y)1.4%

ROE(5y)4.65%

ROIC(3y)8.77%

ROIC(5y)8.58%

ROICexc(3y)19.44%

ROICexc(5y)18.53%

ROICexgc(3y)71.44%

ROICexgc(5y)100.96%

ROCE(3y)11.34%

ROCE(5y)10.99%

ROICexgc growth 3Y-17.24%

ROICexgc growth 5YN/A

ROICexc growth 3Y-9.08%

ROICexc growth 5YN/A

OM growth 3Y-6%

OM growth 5YN/A

PM growth 3Y-3.63%

PM growth 5YN/A

GM growth 3Y-1.02%

GM growth 5YN/A

F-Score4

Asset Turnover1

Health

		Industry Rank	Sector Rank
Debt/Equity	0.4
Debt/FCF	N/A
Debt/EBITDA	2.97
Cap/Depr	27.37%
Cap/Sales	0.75%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.31
Quick Ratio	0.99
Altman-Z	2.13

F-Score4

WACC7.02%

ROIC/WACC0.53

Cap/Depr(3y)33.88%

Cap/Depr(5y)34.44%

Cap/Sales(3y)0.94%

Cap/Sales(5y)0.82%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-68.84%

EPS 3Y-13.22%

EPS 5YN/A

EPS Q2Q%-48.59%

EPS Next Y-12.2%

EPS Next 2Y38.63%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-30.53%

Revenue growth 3Y-9.93%

Revenue growth 5YN/A

Sales Q2Q%-26.54%

Revenue Next Year-11.32%

Revenue Next 2Y2.8%

Revenue Next 3YN/A

Revenue Next 5Y3.02%

EBIT growth 1Y-50.48%

EBIT growth 3Y-15.33%

EBIT growth 5YN/A

EBIT Next Year75%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-136.13%

FCF growth 3Y-29.75%

FCF growth 5YN/A

OCF growth 1Y-114.31%

OCF growth 3Y-21.91%

OCF growth 5YN/A

HEXAOM / ALHEX.PA FAQ

What is the fundamental rating for ALHEX stock?

ChartMill assigns a fundamental rating of 4 / 10 to ALHEX.PA.

What is the valuation status for ALHEX stock?

ChartMill assigns a valuation rating of 4 / 10 to HEXAOM (ALHEX.PA). This can be considered as Fairly Valued.

How profitable is HEXAOM (ALHEX.PA) stock?

HEXAOM (ALHEX.PA) has a profitability rating of 4 / 10.

What are the PE and PB ratios of HEXAOM (ALHEX.PA) stock?

The Price/Earnings (PE) ratio for HEXAOM (ALHEX.PA) is 26.26 and the Price/Book (PB) ratio is 1.04.

Can you provide the financial health for ALHEX stock?

The financial health rating of HEXAOM (ALHEX.PA) is 4 / 10.

HEXAOM (ALHEX.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens

HEXAOM / ALHEX.PA FAQ

What is the fundamental rating for ALHEX stock?

What is the valuation status for ALHEX stock?

How profitable is HEXAOM (ALHEX.PA) stock?

What are the PE and PB ratios of HEXAOM (ALHEX.PA) stock?

Can you provide the financial health for ALHEX stock?